儿童肥胖、体重变化与小儿免疫介导性皮肤病
该纵向队列分析2009至2020年2,161,900名韩国儿童,探讨体重指数及其变化与三种免疫介导性皮肤病(斑秃、特应性皮炎、银屑病)的关联。结果显示肥胖儿童患病风险高于正常体重儿童,体重增加与特应性皮炎风险升高相关,而体重减轻则与风险降低相关。
要点
- 肥胖儿童患免疫介导性皮肤病的风险高于正常体重儿童。
- 体重指数增加与特应性皮炎风险升高相关,体重减轻则风险降低。
- 从正常体重转为超重者特应性皮炎风险增加。
核心结论
- 儿童期肥胖可能增加小儿免疫介导性皮肤病的风险。
- 体重增加可能升高特应性皮炎风险,体重减轻可能降低该风险。
研究设计与样本
- 纵向队列研究,纳入2009至2020年韩国儿童2,161,900名。
主要发现
- 肥胖儿童患小儿免疫介导性皮肤病的风险高于正常体重儿童(趋势P < .01)。
- 体重指数增加与特应性皮炎风险升高相关,体重指数降低与特应性皮炎风险降低相关。
- 从正常体重转为超重者特应性皮炎风险高于维持正常体重者(校正风险比 = 1.15,95%置信区间 = 1.11-1.20)。
- 从超重转为正常体重者特应性皮炎风险低于维持超重者(校正风险比 = 0.87,95%置信区间 = 0.81-0.94)。
临床怎么用
- 临床评估小儿免疫介导性皮肤病时,可关注体重状态及体重变化史。
- 对超重或肥胖儿童,控制体重可能有助于降低特应性皮炎风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Whether childhood obesity or weight gain leads to the development of pediatric immune-mediated skin diseases remains unclear. We aimed to determine the associations between body mass index or body mass index changes and the development of 3 main immune-mediated skin diseases-alopecia areata, atopic dermatitis (AD), and psoriasis-by analyzing a longitudinal cohort of 2,161,900 Korean children from 2009 to 2020. The findings indicated that children who were obese had a higher risk of pediatric immune-mediated skin diseases than those with normal weight (P for trend < .01). An increase in body mass index was associated with a higher risk of AD, whereas a decrease in body mass index was correlated with a reduced risk of AD. Children who gained weight, transitioning from normal to overweight, exhibited a higher AD risk than those who maintained a normal weight (adjusted hazard ratio = 1.15, 95% confidence interval = 1.11-1.20). However, those who shifted from being overweight to achieving a normal weight (adjusted hazard ratio = 0.87, 95% confidence interval = 0.81-0.94) had a lower AD risk than children who were overweight who maintained their weight. In summary, early childhood obesity may increase the risk of pediatric immune-mediated skin diseases. Weight gain may increase AD risk, whereas weight loss may lower the risk.
引用
- Kim SR, Koh SJ, Park H, et al. Childhood Obesity, Weight Change, and Pediatric Immune-Mediated Skin Diseases. J Invest Dermatol. 2024. PMID: 39177545. doi:10.1016/j.jid.2024.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。